↓ Skip to main content

Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study

Overview of attention for article published in Orphanet Journal of Rare Diseases, September 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
1 news outlet
twitter
6 X users
patent
1 patent
wikipedia
1 Wikipedia page

Citations

dimensions_citation
260 Dimensions

Readers on

mendeley
285 Mendeley